Clinical Trial Update: Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of Viaskin Milk, an epicutaneous immunotherapy patch containing milk protein, in children with IgE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cow Milk Allergy

Drugs mentioned

• Viaskin Milk (epicutaneous immunotherapy patch containing milk protein)

Snippet

Sponsor: DBV Technologies | Conditions: Food Allergy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-20